Quite a busy week of fund raises, IPOs and deals to summarise across MedTech and Biotech. Here is Matt Lowdon‘s highlights in his weekly update. Congratulations to all involved. ➡️ Roche inks $200M-plus licensing pact for Freenome‘s cancer screening blood tests ➡️…
Read MoreMonth: November 2025

